These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 7529134

  • 21. Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer.
    Härkönen P, Kyllönen AP, Nordling S, Vihko P.
    Prostate; 2005 Feb 15; 62(3):267-74. PubMed ID: 15389780
    [Abstract] [Full Text] [Related]

  • 22. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
    El Gammal AT, Brüchmann M, Zustin J, Isbarn H, Hellwinkel OJ, Köllermann J, Sauter G, Simon R, Wilczak W, Schwarz J, Bokemeyer C, Brümmendorf TH, Izbicki JR, Yekebas E, Fisch M, Huland H, Graefen M, Schlomm T.
    Clin Cancer Res; 2010 Jan 01; 16(1):56-64. PubMed ID: 20028754
    [Abstract] [Full Text] [Related]

  • 23. [Molecular pathology of prostate carcinoma. Academic playground or guide for diagnosis and therapy planning?].
    Bubendorf L.
    Verh Dtsch Ges Pathol; 2004 Jan 01; 88():158-64. PubMed ID: 16892547
    [Abstract] [Full Text] [Related]

  • 24. Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia.
    Koivisto PA, Schleutker J, Helin H, Ehren-van Eekelen C, Kallioniemi OP, Trapman J.
    Clin Cancer Res; 1999 Nov 01; 5(11):3578-82. PubMed ID: 10589774
    [Abstract] [Full Text] [Related]

  • 25. Accuracy of an array comparative genomic hybridization (CGH) technique in detecting DNA copy number aberrations: comparison with conventional CGH and loss of heterozygosity analysis in prostate cancer.
    Yano S, Matsuyama H, Matsuda K, Matsumoto H, Yoshihiro S, Naito K.
    Cancer Genet Cytogenet; 2004 Apr 15; 150(2):122-7. PubMed ID: 15066319
    [Abstract] [Full Text] [Related]

  • 26. Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer.
    Hidaka S, Yasutake T, Kondo M, Takeshita H, Yano H, Haseba M, Tsuji T, Sawai T, Nakagoe T, Tagawa Y.
    Anticancer Res; 2003 Apr 15; 23(4):3353-7. PubMed ID: 12926075
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M, Li M, Fu X, Huang Y, Qian H, Sun R, Mao Y, Xie Y, Li Y.
    Prostate; 2008 Oct 01; 68(14):1496-509. PubMed ID: 18366025
    [Abstract] [Full Text] [Related]

  • 29. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
    Aalto Y, Eriksson L, Seregard S, Larsson O, Knuutila S.
    Invest Ophthalmol Vis Sci; 2001 Feb 01; 42(2):313-7. PubMed ID: 11157859
    [Abstract] [Full Text] [Related]

  • 30. Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy.
    Nakao K, Shibusawa M, Ishihara A, Yoshizawa H, Tsunoda A, Kusano M, Kurose A, Makita T, Sasaki K.
    Cancer; 2001 Feb 15; 91(4):721-6. PubMed ID: 11241239
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Molecular genetic progression on nasopharyngeal carcinoma].
    Shao JY, Zeng WF, Zeng YX.
    Ai Zheng; 2002 Jan 15; 21(1):1-10. PubMed ID: 12500388
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.
    Kobayashi M, Ishida H, Shindo T, Niwa S, Kino M, Kawamura K, Kamiya N, Imamoto T, Suzuki H, Hirokawa Y, Shiraishi T, Tanizawa T, Nakatani Y, Ichikawa T.
    Prostate; 2008 Dec 01; 68(16):1715-24. PubMed ID: 18781578
    [Abstract] [Full Text] [Related]

  • 36. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation.
    Kiechle M, Jacobsen A, Schwarz-Boeger U, Hedderich J, Pfisterer J, Arnold N.
    Cancer; 2001 Feb 01; 91(3):534-40. PubMed ID: 11169935
    [Abstract] [Full Text] [Related]

  • 37. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
    van Duin M, van Marion R, Vissers K, Watson JE, van Weerden WM, Schröder FH, Hop WC, van der Kwast TH, Collins C, van Dekken H.
    Genes Chromosomes Cancer; 2005 Dec 01; 44(4):438-49. PubMed ID: 16130124
    [Abstract] [Full Text] [Related]

  • 38. DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies.
    Sun J, Liu W, Adams TS, Sun J, Li X, Turner AR, Chang B, Kim JW, Zheng SL, Isaacs WB, Xu J.
    Prostate; 2007 May 15; 67(7):692-700. PubMed ID: 17342750
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma.
    Aalto Y, Nordling S, Kivioja AH, Karaharju E, Elomaa I, Knuutila S.
    Genes Chromosomes Cancer; 1999 Jun 15; 25(2):104-7. PubMed ID: 10337993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.